Fragmented research
Concentrated in a handful of academic centres, with limited national coordination, no widespread registry, and constrained dedicated funding.
CADASIL is a rare, complex condition that touches patients, families, clinicians, and researchers across many geographies. We were founded to help connect them — patient-first, science-anchored, and globally connected.
To improve the lives of individuals and families affected by CADASIL by accelerating awareness, enabling earlier diagnosis, supporting research, and strengthening support systems.
A world where CADASIL is recognized early, accurately diagnosed, actively researched, and supported through coordinated care.
CADASIL is the most common monogenic cause of stroke in adults — and it is also rare, complex, and often under-recognized outside specialized academic centres. Closing the gap between what is known clinically and what reaches patients, families, and everyday clinicians is what we're built to help with.
Concentrated in a handful of academic centres, with limited national coordination, no widespread registry, and constrained dedicated funding.
Patients commonly report years — sometimes decades — between first symptoms and a confirmed CADASIL diagnosis.
Clear care pathways, accessible educational materials, and peer community are uneven across health systems and geographies.
Each pillar is built around a measurable outcome — not just an aspiration.
We make CADASIL easier to recognize and easier to understand — for patients and families navigating a new diagnosis, for clinicians who may see CADASIL only once in a career, and for a wider public that is still learning the name.
The more people who are recognized and diagnosed, the more people are able to take part in CADASIL research. We help by using our awareness work to support earlier diagnosis, and by pointing patients and families toward research opportunities as we come across them.
Life with CADASIL touches whole families — patients, partners, parents, and children. We're building the kind of resource we wish had been there at diagnosis: honest, practical, and grounded in the experience of people who have lived it.
CADASIL often sits in the space between stroke medicine and rare-disease work — and it can be easy to miss in either. We speak up for the community in both worlds and work alongside organizations that share our goals, so more people find the right conversation at the right time.
How we work is small, careful, and connected. We take our cues from people living with CADASIL, check our medical content with clinicians, and work alongside the organizations already doing good work in this space.

Honest about what we know — and what we don't. Evidence over speculation. People over platforms.
Built for patients and families across geographies, languages, and backgrounds. CADASIL does not discriminate; neither do we.
Every delayed diagnosis has a cost. We move with the urgency the disease demands.
We do not duplicate; we connect. Our partners include patient organizations, academic centres, and policy bodies.
The science is moving. We meet that progress with the awareness, infrastructure, and community it deserves.
From clinical accuracy to design craft, every artifact we produce should earn the trust of the people who rely on it.
Awareness that spreads on the wind. Hope amid fragility. Resilience across generations. Vascular branching echoed in nature. The dandelion sits beside our clinical imagery as a reminder that this is, at its heart, a human story.
CADASIL Global Foundation partners with the Sunnybrook Foundation as the fundraising pathway for CADASIL research at Sunnybrook — one of Canada's leading academic health centres. Donations through this pathway support CADASIL research at Sunnybrook.